We observed that the risk of PCa in IBD patients were of borderline significant increase (pooled SIR:1.09; 95% CI: 0.95–1.22; I 2 =61.2%; Figure 2 ) when compared with the background population, as was the risk of UC subgroup (pooled SIR: 1.13; 95% CI: 0.93–1.33; I 2 =73.5%; Figure 2 ) and CD subgroup (pooled SIR: 1.07; 95% CI: 0.93–1.20; I 2 =15.1%; Figure 2 ).
← all excerpts
Inflammatory bowel disease and risk of urinary cancers: a systematic review and pooled analysis of population-based studies.
1
—
—